Advantages of L-3-[18F] fluoro-alpha-methyl tyrosine over 2-[18F]-fluoro-2-deoxyglucose in detecting liver metastasis during positron emission tomography scan
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2193-1801
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Advantages of L-3-[18F] fluoro-alpha-methyl tyrosine over 2-[18F]-fluoro-2-deoxyglucose in detecting liver metastasis during positron emission tomography scan ; volume:5 ; number:1 ; day:13 ; month:5 ; year:2016 ; pages:1-9 ; date:12.2016
SpringerPlus ; 5, Heft 1 (13.5.2016), 1-9, 12.2016
- Creator
-
Kodaira, Sayaka
- Contributor
-
Nakajima, Takahito
Arisaka, Yukiko
Tokue, Azusa
Higuchi, Tetsuya
Tsushima, Yoshito
SpringerLink (Online service)
- DOI
-
10.1186/s40064-016-2212-7
- URN
-
urn:nbn:de:1111-2016051816734
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kodaira, Sayaka
- Nakajima, Takahito
- Arisaka, Yukiko
- Tokue, Azusa
- Higuchi, Tetsuya
- Tsushima, Yoshito
- SpringerLink (Online service)
Other Objects (12)
![Metabolism of no-carrier-added 2-[18F]fluoro-L-tyrosine in rats](/assets/placeholder/searchResultMediaUnknown.png)
Metabolism of no-carrier-added 2-[18F]fluoro-L-tyrosine in rats
Appearance of adrenal myelolipomas on 2-deoxy-2-(18F) fluoro-D-glucose positron emission tomography-computed tomography
Positron emission tomography agent 2-deoxy-2-[18F]fluoro-D-glucose has a therapeutic potential in breast cancer
Test-Retest Stability of Cerebral 2-Deoxy-2-[18F]Fluoro-D-Glucose ([18F]FDG) Positron Emission Tomography (PET) in Male and Female Rats
Assessment of diffuse Lewy body disease by 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET)
Using 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG) to study carbon allocation in plants after herbivore attack
Role of brain 2-[18F]fluoro-2-deoxy-D-glucose-positron-emission tomography as survival predictor in amyotrophic lateral sclerosis
![Rechtliche Aspekte und praktische Umsetzung der Herstellung von kurzlebigen Radiopharmaka am Beispiel von 2-[18F]Fluoro-2-deoxyglucose ([18F]FDG)](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Rechtliche Aspekte und praktische Umsetzung der Herstellung von kurzlebigen Radiopharmaka am Beispiel von 2-[18F]Fluoro-2-deoxyglucose ([18F]FDG)
Monitoring Response to Radiotherapy in Human Squamous Cell Cancer Bearing Nude Mice: Comparison of 2′-deoxy-2′-[18F]fluoro-d-glucose (FDG) and 3′-[18F]fluoro-3′-deoxythymidine (FLT)
Optimal 2-[18F]fluoro-2-deoxy-d-galactose PET/CT protocol for detection of hepatocellular carcinoma
Spatial relationship of 2-deoxy-2-[18F]-fluoro-D-glucose positron emission tomography and magnetic resonance diffusion imaging metrics in cervical cancer
Wertigkeit der Positronen-Emissions-Tomographie mit 2-[18F]-Fluoro-2-Deoxy-D-Glukose in der Rezidivdiagnostik des Ovarialkarzinoms
Metabolism of no-carrier-added 2-[18F]fluoro-L-tyrosine in rats
Appearance of adrenal myelolipomas on 2-deoxy-2-(18F) fluoro-D-glucose positron emission tomography-computed tomography
Positron emission tomography agent 2-deoxy-2-[18F]fluoro-D-glucose has a therapeutic potential in breast cancer
Test-Retest Stability of Cerebral 2-Deoxy-2-[18F]Fluoro-D-Glucose ([18F]FDG) Positron Emission Tomography (PET) in Male and Female Rats
Assessment of diffuse Lewy body disease by 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET)
Using 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG) to study carbon allocation in plants after herbivore attack
Role of brain 2-[18F]fluoro-2-deoxy-D-glucose-positron-emission tomography as survival predictor in amyotrophic lateral sclerosis
Rechtliche Aspekte und praktische Umsetzung der Herstellung von kurzlebigen Radiopharmaka am Beispiel von 2-[18F]Fluoro-2-deoxyglucose ([18F]FDG)
Monitoring Response to Radiotherapy in Human Squamous Cell Cancer Bearing Nude Mice: Comparison of 2′-deoxy-2′-[18F]fluoro-d-glucose (FDG) and 3′-[18F]fluoro-3′-deoxythymidine (FLT)
Optimal 2-[18F]fluoro-2-deoxy-d-galactose PET/CT protocol for detection of hepatocellular carcinoma
Spatial relationship of 2-deoxy-2-[18F]-fluoro-D-glucose positron emission tomography and magnetic resonance diffusion imaging metrics in cervical cancer
Wertigkeit der Positronen-Emissions-Tomographie mit 2-[18F]-Fluoro-2-Deoxy-D-Glukose in der Rezidivdiagnostik des Ovarialkarzinoms
Metabolism of no-carrier-added 2-[18F]fluoro-L-tyrosine in rats
Appearance of adrenal myelolipomas on 2-deoxy-2-(18F) fluoro-D-glucose positron emission tomography-computed tomography
Positron emission tomography agent 2-deoxy-2-[18F]fluoro-D-glucose has a therapeutic potential in breast cancer
Test-Retest Stability of Cerebral 2-Deoxy-2-[18F]Fluoro-D-Glucose ([18F]FDG) Positron Emission Tomography (PET) in Male and Female Rats
Assessment of diffuse Lewy body disease by 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET)
Using 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG) to study carbon allocation in plants after herbivore attack
Role of brain 2-[18F]fluoro-2-deoxy-D-glucose-positron-emission tomography as survival predictor in amyotrophic lateral sclerosis
Rechtliche Aspekte und praktische Umsetzung der Herstellung von kurzlebigen Radiopharmaka am Beispiel von 2-[18F]Fluoro-2-deoxyglucose ([18F]FDG)
Monitoring Response to Radiotherapy in Human Squamous Cell Cancer Bearing Nude Mice: Comparison of 2′-deoxy-2′-[18F]fluoro-d-glucose (FDG) and 3′-[18F]fluoro-3′-deoxythymidine (FLT)
Optimal 2-[18F]fluoro-2-deoxy-d-galactose PET/CT protocol for detection of hepatocellular carcinoma
Spatial relationship of 2-deoxy-2-[18F]-fluoro-D-glucose positron emission tomography and magnetic resonance diffusion imaging metrics in cervical cancer